Pelletier-Galarneau M, et al. Detection of native and prosthetic valve endocarditis: incremental attributes of functional FDG PET/CT over Morphologic Imaging. Curr Cardiol Rep. 2020;22(9):93.

Article  PubMed  Google Scholar 

Pelletier-Galarneau M et al. Arrhythmias in Nongranulomatous myocarditis: is there a role for PET? J Nucl Med, 2024.

Trivedi SJ, Bourque JM. Innovations in imaging: (18)F-Fluorodeoxyglucose PET/CT for Assessment of Cardiovascular Infection and inflammation. Curr Cardiol Rep; 2024.

Google Scholar 

Xie B, et al. 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging in atrial fibrillation: a pilot prospective study. Eur Heart J Cardiovasc Imaging. 2021;23(1):102–12.

Article  PubMed  Google Scholar 

Marchandise S, et al. Left atrial glucose metabolism evaluation by 18F-FDG-PET in Persistent Atrial Fibrillation and in Sinus Rhythm. JACC: Basic Translational Sci. 2024;9(4):459–71.

Google Scholar 

Sinigaglia M, et al. FDG atrial uptake is associated with an increased prevalence of stroke in patients with atrial fibrillation. Eur J Nucl Med Mol Imaging. 2019;46(6):1268–75.

Article  PubMed  Google Scholar 

Wan P, Yu WB. Right atrial wall inflammation detected by 18F-FDG PET/CT may be significantly associated with persistent atrial fibrillation: a prospective case-control study. BMC Cardiovasc Disord. 2023;23(1). https://doi.org/10.1186/s12872-023-03592-2.

Watanabe E, et al. Positron emission tomography/computed tomography detection of increased < sup > 18 F-fluorodeoxyglucose uptake in the cardiac atria of patients with atrial fibrillation. Int J Cardiol. 2019;283:171–7.

Wan P, et al. The relationship between right atrial wall inflammation and poor prognosis of atrial fibrillation based on 18F-FDG positron emission tomography/computed tomography. Quant Imaging Med Surg. 2024;14(2):1369–82.

Article  PubMed  PubMed Central  Google Scholar 

Wang B, et al. Right atrial fluorodeoxyglucose uptake is a risk factor for stroke and improves prediction of Stroke above the CHA2DS2-VASc score in patients with Atrial Fibrillation. Frontiers in Cardiovascular Medicine; 2022.

Book  Google Scholar 

Xie B, et al. Factors relevant to atrial (18)F-fluorodeoxyglucose uptake in atrial fibrillation. J Nucl Cardiol. 2020;27(5):1501–12.

Article  PubMed  Google Scholar 

Abohashem S, Aldosoky W, Osborne MT. Atrial FDG uptake linked to ischemic stroke in patients without atrial fibrillation. J Nucl Cardiol. 2022;29(6):3204–6.

Article  PubMed  PubMed Central  Google Scholar 

Fujimoto Y, et al. Prevalence and prognostic value of atrial fibrillation in patients with cardiac sarcoidosis. Eur Heart J Open. 2023;3(5):oead100.

Article  PubMed  PubMed Central  Google Scholar 

Iwai K, et al. Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn. 1993;43(7–8):372–6.

CAS  PubMed  Google Scholar 

Perry A, Vuitch F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med. 1995;119(2):167–72.

CAS  PubMed  Google Scholar 

Hu YF, et al. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015;12(4):230–43.

Article  CAS  PubMed  Google Scholar 

Pelletier-Galarneau M, et, Martineau P. éditeurs. FDG-PET/CT and PET/MR in Cardiovascular Diseases. Springer International Publishing, 2022.

Patel VN, et al. The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis. J Nucl Cardiol. 2022;29(5):2460–70.

Article  PubMed  Google Scholar 

Yodogawa K, et al. Prevalence of atrial FDG uptake and association with atrial arrhythmias in patients with cardiac sarcoidosis. Int J Cardiol. 2020;313:55–9.

Article  PubMed  Google Scholar 

Niemelä M, et al. Incidence and predictors of Atrial Fibrillation in Cardiac Sarcoidosis: a Multimodality Imaging Study. JACC Cardiovasc Imaging. 2022;15(9):1622–31.

Article  PubMed  Google Scholar 

Rosenthal DG, et al. Association between Sarcoidosis and Atrial Fibrillation among californians using Medical Care. JACC Clin Electrophysiol. 2021;7(12):1620–2.

Article  PubMed  Google Scholar 

Sama C, et al. A systematic review and meta-analysis of the prevalence, incidence, and predictors of atrial fibrillation in cardiac sarcoidosis. Int J Cardiol. 2023;391:131285.

Article  PubMed  Google Scholar 

Hutt E, et al. CHARACTERISTICS AND OUTCOMES OF ATRIAL FIBRILLATION IN CARDIAC SARCOIDOSIS. J Am Coll Cardiol. 2021;77(18Supplement1):621–621.

Article  Google Scholar 

de Bortoli A, Birnie DH. Incidence of Atrial Fibrillation in Cardiac Sarcoidosis. JACC Cardiovasc Imaging. 2023;16(2):262–3.

Article  PubMed  Google Scholar 

Larsen BT, et al. Atrial giant cell myocarditis: a distinctive clinicopathologic entity. Circulation. 2013;127(1):39–47.

Article  PubMed  Google Scholar 

Arai H, et al. Images of atrial giant cell myocarditis. Eur Heart J - Cardiovasc Imaging. 2018;19(2):243–243.

Article  PubMed  Google Scholar 

Kushnir A, Restaino SW, Yuzefpolskaya M. Giant cell arteritis as a cause of Myocarditis and Atrial Fibrillation. Circulation: Heart Fail. 2016;9(2):e002778.

Google Scholar 

Lim CP, et al. A rare case of isolated atrial myocarditis. Singap Med J. 2021;62(11):610–4.

Article  Google Scholar 

James OG, et al. Utility of FDG PET/CT in inflammatory cardiovascular disease. Radiographics. 2011;31(5):1271–86.

Article  PubMed  Google Scholar 

Larsen BC, et al. Inflammatory-mediated atrial cardiomyopathy diagnosed using multimodality imaging and successfully treated with prednisolone: a case report. Eur Heart J Case Rep. 2024;8(4):ytae167.

Article  PubMed  PubMed Central  Google Scholar 

Ahmed A, et al. PO-01-087 < strong > a RARE CASE OF BI-ATRIAL FDG-UPTAKE: PRESENTING AS NEW ONSET ATRIAL FIBRILLATION. Heart Rhythm. 2023;20(5):S204.

Article  Google Scholar 

Ghazal R, et al. A rare case of New-Onset Atrial Fibrillation presenting as biatrial inflammation seen on (18)F-FDG-PET. JACC Case Rep. 2023;28:p102114.

Article  Google Scholar 

Trachtenberg BH, Hare JM. Inflamm Cardiomyopathic Syndr Circ Res. 2017;121(7):803–18.

CAS  Google Scholar 

Ekström K et al. Incidence, risk factors, and outcome of life-threatening ventricular arrhythmias in giant cell myocarditis. Circ Arrhythm Electrophysiol, 2016. 9(12).

Ekström K, et al. Long-term outcome and its predictors in giant cell myocarditis. Eur J Heart Fail. 2016;18(12):1452–1458.

Article  PubMed  Google Scholar 

Minamimoto R. Series of myocardial FDG uptake requiring considerations of myocardial abnormalities in FDG-PET/CT. Jpn J Radiol. 2021;39(6):540–57.

Article  PubMed  PubMed Central  Google Scholar 

Pharr JR, et al. Prominent crista terminalis appearing as a right atrial mass on transthoracic echocardiogram. J Am Soc Echocardiogr. 2002;15(7):753–5.

Article  PubMed  Google Scholar 

Yang T, et al. The ratio of (18)F-FDG activity uptake between the right and left ventricle in patients with pulmonary hypertension correlates with the right ventricular function. Clin Nucl Med. 2014;39(5):426–30.

Article  PubMed  Google Scholar 

Fan CM, et al. Lipomatous hypertrophy of the interatrial septum: increased uptake on FDG PET. AJR Am J Roentgenol. 2005;184(1):339–42.

Article  PubMed  Google Scholar 

Xanthos T, Giannakopoulos N, Papadimitriou L. Lipomatous hypertrophy of the interatrial septum: a pathological and clinical approach. Int J Cardiol. 2007;121(1):4–8.

Article  PubMed  Google Scholar